Extracorporeal therapy and drug monitoring for infections
Part of Infections clinical trials.
This trial studies how well certain new antibiotics work in patients with gram-negative bacterial infections who are receiving extracorporeal life support (like ECMO or dialysis) in the intensive care unit. It uses drug monitoring to make sure the right dose is given.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are admitted to the intensive care unit (ICU)
- You have a gram-negative bacterial infection that can be treated with newer antibiotics
- You may or may not be on ECMO (heart-lung bypass) or kidney dialysis (RRT)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at an add-on blood-filter treatment used in the ICU to help remove harmful substances like waste products, inflammation signals, or toxins from the blood. Results may help doctors understand whether this approach improves care and how it should be used.
This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.
This trial tests a specific type of blood-filter treatment in critically ill ICU patients who have acute kidney injury and/or failure of other organs. It aims to see whether these filters can improve care by supporting kidney function and/or calming harmful inflammation.
This study looks at how well antibiotics and other anti-infective drugs work in very sick patients who are on a heart-lung machine called ECMO. If you're in the ICU with a serious infection, this trial could help doctors figure out the best dose for you.
This trial tests whether adding an inhaled antibiotic (amikacin) to standard IV antibiotics can better treat a serious lung infection (pneumonia caused by Gram-negative bacteria) in patients on a heart-lung machine (ECMO) and a breathing tube. If you or your loved one is on ECMO and has this type of pneumonia, this study may offer a new treatment approach.
This study looks at how well certain strong antibiotics (Piperacillin-Tazobactam, Cefepime, or Meropenem) work in the body when a person is on a heart-lung machine called VA-ECMO. It aims to find the best dose for these antibiotics in this situation.
Hear when a new ICU Patients With ECMO And-or RRT and With Gram Negative Infections Susceptible to BL-BLIs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.